The HDAC inhibitor SAHA also demonstrated capabilities of slowing down tumor proliferation and triggering autophagy in GSCs, rather than induction of differentiation seen with TSA and valproic acid[65]. The gene discussed is HDAC9; the disease is neoplasm.